Skip to main content
IMS Events Main banner
Back

    Krina K. Patel, MD (she/her/hers)

    Associate Professor
    MD Anderson Cancer Center, University of Texas, Houston, TX, USA
    Houston, Texas, United States

    Dr. Krina K. Patel is an associate professor in the Department of Lymphoma and Myeloma, Division of Cancer Medicine, and was previously in the Department of Stem Cell Transplantation, at the University of Texas MD Anderson Cancer Center (UT MDACC) in Houston. She earned her BA at the University of Pennsylvania and her medical degree from the University of Texas Southwestern Medical Center, Dallas. She completed a fellowship in hematology-oncology at UT MDACC where she served as Chief fellow for 2 years. She currently serves as the Service Line Leader for her department.

    Dr Patel’s research focus is on improving therapy and outcomes for patients with multiple myeloma (MM) and other plasma cell dyscrasias. Her specific research interests include: MM, POEMS, plasmablastic lymphoma, and developing cellular therapy such as chimeric antigen receptor T cells with or without transplant; and combining immunotherapy in the induction, transplant, maintenance, and salvage settings. She has acted as principal investigator on several MM clinical trials with a focus on immunotherapies. She is Co-PI on a translational project evaluating potential biomarkers for response with SOC CART and serves as chair of the Multiple Myeloma CAR T Consortium which evaluates outcomes for cellular therapy in the real world setting. She enjoys teaching and mentoring residents, APPs and fellows in hopes to continue to improve access and outcomes for patients with plasma cell dyscrasias.

    Dr Patel is a member of the American Society for Blood and Marrow Transplantation, the American Association for Cancer Research, the American Society of Hematology, the American Society of Clinical Oncology and the International Myeloma Society. Her research has been published in numerous peer-reviewed journals.

    Disclosure information not submitted.

    Presentation(s):